• Mashup Score: 9

    Access this webinar on Gender differences in valvular heart disease: focus on aortic stenosis and more with Professor A. Chieffo (Italy,IT),Associate Professor J. Grapsa (United Kingdom of Great Britain & Northern Ireland,GB), Professor B. Cosyns (Belgium,BE),Doctor A. Franzone (Italy,IT),Doctor G. Mandoli (Italy,IT).

    Tweet Tweets with this article
    • Don’t miss @escardio webinar on #gender differences in #aorticstenosis with @alaide_chief @Cosyns @DrGEMandoli @franzone_anna - Register today ➡️ https://t.co/vmt9YuDC9F @ESC_Journals @AnastasiaSMihai @rafavidalperez @VDelgadoGarcia @EACVIPresident @EAPCIPresident @ShehabAnwer… https://t.co/hYT4MbJlHD https://t.co/BINg3EG2CG

  • Mashup Score: 0

    Patients with moderate to severe aortic stenosis had similar outcomes to patients with severe aortic stenosis, whereas those with moderate aortic stenosis were comparable to those with mild aortic stenosis, researchers reported.The researchers conducted the KP-VALVE project using artificial intelligence algorithms to determine the association between physician-assessed aortic stenosis severity,

    Tweet Tweets with this article
    • Patients with moderate to severe aortic stenosis had similar outcomes to patients with severe #AorticStenosis, whereas those with moderate aortic stenosis were comparable to those with mild aortic stenosis @kpnorcal @MDSolomonMD #cardiotwitter https://t.co/wm9GUAWJoi

  • Mashup Score: 11

    Hear Peter Libby, Deepak Bhatt, Franz Messerli, Roxana Mehran, Tom Guzik, and many more discussing the latest science that can impact your practice. 

    Tweet Tweets with this article
    • New #ESCCardioTalk podcast 🤗🎙️ Gregg Pressman & Christian Witzke-Sanz discuss: Aortic stenosis: new insights into predicting disease progression https://t.co/688tkrAs93 #EHJCI #CVD #cardiotwitter #aorticvalve #echocardiography #aorticstenosis https://t.co/Bz725az6xZ

  • Mashup Score: 0

    July 21, 2023 — Onecrea Medical has announced the success of the first-in-human implants of its Transcatheter Aortic Valve Replacement (TAVR) system for the treatment of aortic stenosis. While TAVR technology has been around since 2007, Onecrea Medical’s team of scientists and engineers worked towards creating a next-generation TAVR. A common complication with the TAVR/ procedures is dislodging of the implant or perivalvular leak (PVL) due to an improper fit of the valve. Onecrea Medical’s valve has a unique concave and convex structure that anchors the valve effectively in the aortic annulus. The valve also features differential radial force in different parts, imparting low or high radial forces to the valve depending on the location within the annulus and aorta. In addition, the delivery system has been improved for greater control and accuracy of valve implantation. Crea Aortic valves are rigorously tested for over 200 million fatigue cycles and over 140 days in animal trials. Thes

    Tweet Tweets with this article
    • @DAICeditor #OnecreaMedical has announced the success of the first-in-human implants of its #Transcatheter #Aortic #Valve Replacement (#TAVR) system for the treatment of #aorticstenosis: https://t.co/TZDGUwzz4P